Successful treatment of lipoatrophy with normal saline  by Margulies, Samantha L. & Morris, Andrea
CASE REPORTSuccessful treatment of lipoatrophy with
normal saline
Samantha L. Margulies, BS,a and Andrea Morris, MDb
Washington, DC, and Rockville, MarylandFrom
He
Pe
Fund
Confl
Corre
Mi
RoKey words: corticosteroids; lipoatrophy; radiculopathy; saline injections.INTRODUCTION
We present a case of lipoatrophy treated success-
fully with intralesional normal saline injections.
Localized lipodystrophy, or lipoatrophy, presents
as focal loss of subcutaneous fat with variable over-
lying skin changes and depth depending on the
cause. Lipoatrophy could result from both oral and
local intralesional corticosteroid use, with the but-
tocks and proximal extremities being the most
commonly affected sites with oral use.1 Minimal
literature exists about corticosteroid-induced lipoa-
trophy. Localized reactions to injected corticoste-
roids are thought to occur in less than 0.5% of cases,
which primarily include hemorrhage, atrophy, sec-
ondary infection, changes in pigment, hypersensi-
tivity reactions, and panniculitis.2 The observed
lipoatrophy typically begins 2 to 3 months after
injection and can resolve spontaneously.3 Here we
report a case of acquired localized lipodystrophy,
which results mostly in cosmetic concerns but has
limited treatment options to offer patients.4 We
describe the technique for intralesional saline in-
jections to assist clinicians in use of this treatment.
Success of this technique has been previously
described, and our case report confirms this previous
report3 but uses different time intervals between
injections.
PATIENT PRESENTATION
A 51-year-old woman presented to our derma-
tology clinic with a 1-year history of 3 depressed,
atrophic white plaques on the left scapula, sacrum,
and right ankle. Her medical history was significant
for bilateral L5 radiculopathy causing bilateral numb-
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these skin lesions. An excisional biopsy, performed
in Taiwan, of a lesion on the left scapula found
shrinkage of the adipocyte, mild myxoid change,
and increased vascularity consistent with lipoatro-
phy. She began treatment with intralesional normal
saline, but treatments ceased once she moved to the
United States. Nine months after her initial presenta-
tion in Taiwan, the patient presented to our derma-
tology clinic with persistent atrophic, white plaques
at the left scapula (Fig 1, A), right sacrum (not
pictured), and right ankle (Fig 1, B). The lesions
had faint overlying telangiectasias. It was unclear
what caused the lipoatrophy. Based on the patient’s
medical history and presentation, we suspected
steroid use in the area. Although the patient did not
recall receiving steroid injections in those areas to
treat her pain, her examination was suspicious for
localized corticosteroid-induced atrophy. A repeat
biopsy was declined by the patient. We resumed
intralesional normal saline injections every 4 weeks,
given that the patient noted that this treatment had
been improving the atrophic areas. Over 9 months,
the patient was given a range of 3 to 12 mL of
intralesional bacteriostatic 0.9% saline to the
depressed areas. The injections were performed
using a 30-gauge needle at a 458 angle into the
dermis of the atrophic plaque and infiltrating several
milliliters until the skin was taut and no longer
depressed. Usually, only one needle entrance to
the center of the lesion was necessary, which
reduced patient discomfort. The amount injected
varied based on the site and the amount of atrophy in
a particular location. As a result of the treatments, the
depression and coloration of the lesions were muchJAAD Case Reports 2015;1:415-7.
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Fig 1. A, An atrophic plaque on patient’s left scapula after two 0.9% intralesional saline
injections (no significant change in appearance from baseline). B, An atrophic plaque on
patient’s right ankle before treatment.
Fig 2. After saline treatment. Resolution of the plaques on (A) patient’s left scapula and (B)
right ankle after 5 monthly and 2 monthly 0.9% intralesional saline injections, respectively. The
areas are no longer atrophic or as noticeably discolored.
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within 5 months (Fig 2, A). The right ankle improved
after 2 injections (Fig 2, B). The right ankle lesion
resolved completely by her last follow-up visit and
did not require as many treatments as the more
atrophic areas on the back.
DISCUSSION
Corticosteroids (glucocorticoids) are commonly
used intralesionally for hypertrophic scars, alopecia,
and other skin conditions. Glucocorticoids suppress
leukocytes from adhering to endothelial cells, which
limits the ability of leukocytes to enter the nearby
tissues and decreases inflammation.5 In addition,
corticosteroids are potent vasoconstrictors, reducing
both oxygen delivery to the wound and re-
epithelialization. Collagen synthesis is also slowed by
the steroid’s antimitotic effects.6 Decreasing inflamma-
tory molecules with intralesional corticosteroid in-
jections can improve scar pliability, shrink scar size,and reduce pain.6 Although steroids such as triamcin-
olone are efficacious in this scenario, side effects can
include subcutaneous tissue atrophy, capillary dila-
tion, andhypopigmentation.7Manyarticles cite known
side effects of the drug. However, it is difficult to find
howmany patients experience corticosteroid-induced
lipoatrophy. One study found that lipoatrophy was
preceded by an injection in 62% of patients.1
Histologically, it has been found that after corti-
costeroid injections, adipocytes decrease in size and
number and are surrounded by hyaline.1,8,9 The fat
cells were noted to resemble embryonic fat cells
because of prominence of vessels, termed involu-
tional fat.8 Macrophages, somewith yellow-gray and
mucin-positive granules have been found in the area
of interest as well.1,2,9 In some instances, macro-
phages were shown to engulf adipose tissue, thereby
becoming lipophages.1,10 As the microscopic find-
ings of the substance engulfed by macrophages
disappeared, the lipoatrophy faded as well.2
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to completely resolve the cosmetic effect of lipoa-
trophy within 4 to 8 weeks of the initial saline
injection.3 In one case report, autologous fat injec-
tion was used to treat atrophy with results noted
6 months after treatment began.11 Intralesional poly-
L-lactic acid acts to induce fibroblast and collagen
formation, has been used for treatment of human
immunodeficiency viruseassociated facial lipoatro-
phy, and was recently reported in a case of
corticosteroid-induced lipoatrophy.12 Maximal
improvement of the lipoatrophy was noted in 3 to
5 months.12
Our patient was followed over a 9-month period.
The alternative treatments mentioned above are
expensive and inconvenient, potentially prohibiting
patients from following through with experimental
treatment. On the other hand, monthly intralesional
bacteriostatic saline can be a convenient and afford-
able treatment for lipoatrophy attributed to intrale-
sional or intra-articular steroids. Our patient had
improvement in the appearance of her skin lesions
while undergoing monthly injections and had no
significant side effects. There may have been faster
improvement if she had undergone weekly injec-
tions as described previously.3 However, further
studies may help determine if a synergistic effect
between time and saline injection is possible, further
delineating the need for injections on a monthly
versus weekly basis. It is hypothesized that injecting
saline where steroid crystals lie would put them back
into suspension, where the crystals could then be
recognized as foreign bodies and naturally removed
from the body.13 Further studies may help elucidate
the mechanism of action and are needed to better
characterize optimal treatment dose and frequency.REFERENCES
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